KRYSP-R

Mount Laurel, United States Founded: 2021 • Age: 5 yrs
Provider of CRISPR technology services for revolutionizing the service sector
Annual revenue - Latest available
Total funding - Funding intelligence
Employees - Tracked headcount
Investors - Known backers
Products 3 Services tracked
Competitors 11 Brand Intelligence

About KRYSP-R

KRYSP-R is a company based in Mount Laurel (United States) founded in 2021 by Yajamana Ramu. KRYSP-R offers products and services including CRISPR Plasmids, Cell Line Generation, and CRISPR Reagents. KRYSP-R operates in a competitive market with competitors including Strateos, SciGenom, Anthology, Seevix and Leveragen, among others.

  • Headquarter Mount Laurel, United States
  • Founders Yajamana Ramu
  • Sectors
    Healthcare
  • Email
    Locked
  • Phone
    Locked
  • Website
    Locked
  • Social
    Locked
  • Legal Name Krysp-R Biotech Private Limited
  • Date of Incorporation 08 Aug, 2024
  • Jurisdiction Bangalore North, Karnataka, India
Operational Areas
Healthcare → Biotechnology, Genomics & Life Sciences Research Unlock Sub-Sector Unlock Segment
Key Metrics
  • Annual Revenue
    Not available
  • Net Profit
    Not available
  • EBITDA
    Not available
  • Latest Funding Round
    Not available
  • Investors
    Not available
  • Employee Count
    Not available
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of KRYSP-R

KRYSP-R offers a comprehensive portfolio of products and services, including CRISPR Plasmids, Cell Line Generation, and CRISPR Reagents.

Product name locked
Category locked
Primary

Plasmids for reliable genome editing applications.

Product name locked
Category locked
Locked

Service to generate cell lines using CRISPR technology.

Product name locked
Category locked
Locked

Reagents for various CRISPR-based research needs.

Funding Insights of KRYSP-R

Premium access

Detailed funding history for KRYSP-R

Round names, dates, amounts, investors, and valuation history require an active premium plan.

  • Round names and dates
  • Funding amounts
  • Participating investors
  • Valuation history

Verified entity values are shown only after access is granted.

Investments & Acquisitions by KRYSP-R

Investments
Premium access

Investment portfolio details for KRYSP-R

Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.

  • Portfolio identities
  • Transaction dates
  • Round details
  • Investment values

Verified entity values are shown only after access is granted.

Financial Statements - KRYSP-R

Premium access

Detailed financials for KRYSP-R

Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.

  • Historical revenue
  • Profit trends
  • Statement rows
  • Financial ratios

Verified entity values are shown only after access is granted.

Krysp-R Comparisons

KRYSP-R Primary company
Description
Provider of CRISPR technology services for revolutionizing t...
Location
Mount Laurel, United States
Founded Year
2021
Annual Revenue
Not available
Net Profit
Not available
EBITDA
Not available
Employees
Not available
Premium access

Peer comparison for KRYSP-R

Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.

  • Named peers
  • Headcount comparison
  • Funding comparison
  • Operating benchmarks

Verified entity values are shown only after access is granted.

+
Add Comparison
Available on Premium

Competitors of KRYSP-R

KRYSP-R operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Strateos, SciGenom, Anthology, Seevix and Leveragen, among others.

Company Name Domain Founded year HQ Location Description
Locked Locked Locked
Provider of cloud based platform provides data driven information for biotech research
Locked Locked Locked
Provider of genome sequencing and bioinformatics services life science and healthcare sector
Locked Locked Locked
Diverse genomes are generated to scale biomanufacturing and digitalize processes.
Locked Locked Locked
Genetically engineered spider silk fibers are produced for industrial uses.
Locked Locked Locked
Customized genetic engineering services are provided using CRISPR technology.
Locked Locked Locked
CRISPR genome editing services for Drosophila and mosquitoes are offered.
Premium access

Detailed competitors of KRYSP-R

Competitor domains, locations, full profiles, and operating metrics require an active premium plan.

  • Domains and locations
  • Full company profiles
  • Operating metrics
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on Krysp-R

Premium access

Complete news archive for KRYSP-R

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about KRYSP-R

KRYSP-R was founded in 2021.

KRYSP-R is headquartered in Mount Laurel, United States. It is registered at Mount Laurel, New Jersey, United States.

KRYSP-R was founded in 2021 and is based in Mount Laurel Township, United States. Operations focus on biotechnology, with services centered on CRISPR technology for genome editing. Plant cell lines are edited for research applications, while gene knock-ins or knockouts are created in mammalian cell lines to examine diseases and potential treatments. The genetic composition and functions of microorganisms are also studied to pinpoint essential drug targets.

KRYSP-R's top competitors include Strateos, SciGenom and Leveragen.

KRYSP-R offers CRISPR Plasmids, Cell Line Generation, and CRISPR Reagents.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available